![]() ![]() “We're launching this in North America today and in China in about exactly a month, and then everywhere else by the end of this year. “In Omnipresence we've put together our 20 years of experience in life sciences sales and marketing and the various digital solutions we have developed over this period, together with the powerful technologies from Microsoft like the Dynamics 365 CRM, LinkedIn, and Office tools,” said Sanjay Virmani, EVP Indegene. The Indegene Omnipresence full stack solution leverages the capabilities and assets of the Microsoft Cloud including the business process suite of Dynamics 365, the Office productivity suite and cloud services, and all of the power of Cortana Analytics, Azure Machine Learning, and the Azure planet-scale compute and security. Until now CRM/SFA choices for life sciences manufacturers have been limited to just one or two global providers especially when looking at full stack solutions, which package together the CRM backbone with the multichannel customer engagement tools as well as some of the supporting content management and analytics capabilities. Indegene's new Commercialization Model provides a much-needed option to enable a truly transformative approach for brand commercialization.Indegene Omnipresence brings a new alternative to the life sciences commercial execution software space. ![]() ![]() Young biopharma companies unencumbered by legacy processes have a distinct advantage in becoming the torch-bearers for the industry. For a company like Genus, committed to affordable care and better patient outcomes, a targeted physician engagement approach using cutting-edge digital commercialization capabilities augurs well for our mission," said Jeffrey Moshal, Chief Executive Officer, Genus Lifesciences. Indegene's technology and data-enabled revenue generation platform coupled with its deep medical and market expertise is unique. "We are extremely pleased to partner with Indegene in our brand commercialization journey. Kapoor also mentioned that four additional co-commercialization assets are being launched by Indegene over the coming 12 months using the Next Generation Commercialization Platform. Our transformative platform will help Genus achieve peak sales faster at a fraction of the traditional cost." Mr. We partnered with Genus Lifesciences, to launch their product Yosprala using our AI-enabled Next Generation Platform. The current model is complex, costly and takes too much time. Gaurav Kapoor, Executive Vice President, Indegene, said, "The pharma industry is looking for new ways to launch and commercialize its products. Indegene's Yosprala launch is a landmark departure from the traditional commercialization approaches that have burdened biopharma companies with hefty costs and extended lead times. Indegene's AI-driven Next Generation Commercialization Platform incorporates sophisticated predictive analytics, proprietary library of digital customer insights, Omnipresence CRM technology and intelligent content to provide a fundamentally new way of launching brands and driving accelerated peak sales through optimized dollar spends. ![]() PRINCETON, New Jersey, Ap/PRNewswire/ - Indegene, a leading transformational partner to lifesciences industry, today disrupted the traditional biopharma launch and commercialization model with the next generation AI-driven launch of Yosprala TM for secondary CAD and stroke prevention. ![]()
0 Comments
Leave a Reply. |